Leerink Partners Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Leerink Partners
Rating: 2.6
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Leerink Partners. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Leerink Partners.

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 179 Last 12 Months
Buy Ratings: 107 Last 12 Months
Sell Ratings: 4 Last 12 Months
Companies Covered: 149 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
NBTX Nanobiotix	$11.57 -6.0%	9/18/2025	Jonathan Chang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$14.00		View details for Leerink Partners rating of Nanobiotix (NASDAQ:NBTX) on 9/18/2025
ROIV Roivant Sciences	$15.04 -0.3%	9/18/2025	David Risinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$18.00 ➝ $22.00	Outperform	View details for Leerink Partners rating of Roivant Sciences (NASDAQ:ROIV) on 9/18/2025
IPHA Innate Pharma	$1.87 -3.6%	9/18/2025	Daina Graybosch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00 ➝ $2.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Innate Pharma (NASDAQ:IPHA) on 9/18/2025
SABS SAB Biotherapeutics	$2.47 -11.5%	9/17/2025		Initiated Coverage	$7.00	Outperform	View details for Leerink Partners rating of SAB Biotherapeutics (NASDAQ:SABS) on 9/17/2025
ATYR aTyr Pharma	$0.99 -5.5%	9/15/2025		Reiterated Rating		Outperform ➝ Market Perform	View details for Leerink Partners rating of aTyr Pharma (NASDAQ:ATYR) on 9/15/2025
SRRK Scholar Rock	$30.84 -5.0%	9/15/2025		Initiated Coverage	$51.00	Outperform	View details for Leerink Partners rating of Scholar Rock (NASDAQ:SRRK) on 9/15/2025
PTGX Protagonist Therapeutics	$62.20 +0.1%	9/12/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$73.00	Outperform	View details for Leerink Partners rating of Protagonist Therapeutics (NASDAQ:PTGX) on 9/12/2025
SRPT Sarepta Therapeutics	$17.43 -5.9%	9/9/2025	Joseph Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$12.00 ➝ $15.00	Market Perform	View details for Leerink Partners rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/9/2025
MTSR Metsera	$33.32 -7.2%	9/9/2025	David Risinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$77.00	Outperform	View details for Leerink Partners rating of Metsera (NASDAQ:MTSR) on 9/9/2025
WVE WAVE Life Sciences	$6.89 -1.0%	9/3/2025		Set Price Target	$26.00		View details for Leerink Partners rating of WAVE Life Sciences (NASDAQ:WVE) on 9/3/2025

MD Pediatrix Medical Group	$16.30 -1.7%	9/5/2025	Whit Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$14.50 ➝ $17.00	Market Perform	View details for Leerink Partners rating of Pediatrix Medical Group (NYSE:MD) on 9/5/2025
MRNA Moderna	$25.24 -0.8%	8/22/2025	Mani Foroohar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$18.00 ➝ $15.00	Underperform	View details for Leerink Partners rating of Moderna (NASDAQ:MRNA) on 8/22/2025
ARCT Arcturus Therapeutics	$20.46 +4.3%	8/22/2025	Lili Nsongo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$63.00 ➝ $54.00	Outperform	View details for Leerink Partners rating of Arcturus Therapeutics (NASDAQ:ARCT) on 8/22/2025
XERS Xeris Biopharma	$7.72 -7.0%	8/19/2025	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$7.00 ➝ $9.00	Outperform	View details for Leerink Partners rating of Xeris Biopharma (NASDAQ:XERS) on 8/19/2025
PINC Premier	$25.75 -2.5%	8/19/2025	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$24.00 ➝ $26.00	Market Perform	View details for Leerink Partners rating of Premier (NASDAQ:PINC) on 8/19/2025
MGNX MacroGenics	$1.62 -6.4%	8/15/2025		Lower Price Target	$8.00 ➝ $5.00	Outperform	View details for Leerink Partners rating of MacroGenics (NASDAQ:MGNX) on 8/15/2025
INSP Inspire Medical Systems	$79.86 -4.2%	8/15/2025	Mike Kratky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$116.00 ➝ $97.00	Market Perform	View details for Leerink Partners rating of Inspire Medical Systems (NYSE:INSP) on 8/15/2025
STTK Shattuck Labs	$2.28 +2.2%	8/14/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$4.00 ➝ $2.00	Outperform	View details for Leerink Partners rating of Shattuck Labs (NASDAQ:STTK) on 8/14/2025
BHVN Biohaven	$14.34 -7.6%	8/12/2025	Marc Goodman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$60.00 ➝ $50.00	Outperform	View details for Leerink Partners rating of Biohaven (NYSE:BHVN) on 8/12/2025
CAH Cardinal Health	$149.56 -0.3%	8/12/2025	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$188.00 ➝ $186.00	Outperform	View details for Leerink Partners rating of Cardinal Health (NYSE:CAH) on 8/12/2025
LLY Eli Lilly and Company	$753.52 -1.2%	8/7/2025	Market Perform Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$715.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Eli Lilly and Company (NYSE:LLY) on 8/7/2025
ADAG Adagene	$2.05 -1.0%	8/6/2025	Daina Graybosch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$7.00	Outperform	View details for Leerink Partners rating of Adagene (NASDAQ:ADAG) on 8/6/2025
XLO Xilio Therapeutics	$0.78 +2.2%	8/6/2025	Daina Graybosch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$2.00	Outperform	View details for Leerink Partners rating of Xilio Therapeutics (NASDAQ:XLO) on 8/6/2025
CYRX CryoPort	$9.97 -0.8%	8/6/2025	Puneet Souda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$16.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of CryoPort (NASDAQ:CYRX) on 8/6/2025
MASS 908 Devices	$7.30 +7.0%	8/5/2025	Puneet Souda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$12.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of 908 Devices (NASDAQ:MASS) on 8/5/2025
CELC Celcuity	$51.88 -5.7%	7/28/2025	Andrew Berens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$28.00 ➝ $60.00	Outperform	View details for Leerink Partners rating of Celcuity (NASDAQ:CELC) on 7/28/2025
ABVX Abivax	$82.30 -1.2%	7/23/2025	Thomas Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$74.00	Outperform	View details for Leerink Partners rating of Abivax (NASDAQ:ABVX) on 7/23/2025
REPL Replimune Group	$3.22 -6.9%	7/22/2025	Jonathan Chang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$21.00 ➝ $3.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Replimune Group (NASDAQ:REPL) on 7/22/2025
SRPT Sarepta Therapeutics	$17.43 -5.9%	7/21/2025		Reiterated Rating		Outperform ➝ Market Perform	View details for Leerink Partners rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/21/2025
ELV Elevance Health	$313.90 -0.6%	7/18/2025	Whit Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$510.00 ➝ $310.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Elevance Health (NYSE:ELV) on 7/18/2025
IDXX IDEXX Laboratories	$656.16 +0.1%	7/17/2025	Daniel Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$580.00 ➝ $600.00	Outperform	View details for Leerink Partners rating of IDEXX Laboratories (NASDAQ:IDXX) on 7/17/2025
ZTS Zoetis	$145.82 -0.9%	7/17/2025	Daniel Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$180.00 ➝ $155.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Zoetis (NYSE:ZTS) on 7/17/2025
ELAN Elanco Animal Health	$19.18 +0.4%	7/17/2025	Daniel Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$18.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Elanco Animal Health (NYSE:ELAN) on 7/17/2025
HSIC Henry Schein	$67.86 -1.0%	7/14/2025	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$75.00		View details for Leerink Partners rating of Henry Schein (NASDAQ:HSIC) on 7/14/2025
PGNY Progyny	$21.62 -4.0%	7/8/2025	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$28.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Progyny (NASDAQ:PGNY) on 7/8/2025
KALV KalVista Pharmaceuticals	$13.17 -5.1%	7/7/2025	Joseph Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$18.00 ➝ $20.00	Outperform	View details for Leerink Partners rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 7/7/2025
COGT Cogent Biosciences	$11.97 -5.9%	7/7/2025	Andrew Berens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$16.00 ➝ $18.00	Outperform	View details for Leerink Partners rating of Cogent Biosciences (NASDAQ:COGT) on 7/7/2025
ABCL AbCellera Biologics	$4.51 -4.4%	7/7/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$5.00	Outperform	View details for Leerink Partners rating of AbCellera Biologics (NASDAQ:ABCL) on 7/7/2025
RYTM Rhythm Pharmaceuticals	$96.06 -2.5%	7/7/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$88.00	Outperform	View details for Leerink Partners rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 7/7/2025
PFE Pfizer	$24.03 -0.5%	4/30/2025		Lower Price Target	$28.00 ➝ $26.00	Market Perform	View details for Leerink Partners rating of Pfizer (NYSE:PFE) on 4/30/2025

ZLAB Zai Lab	$32.65 -1.1%	6/30/2025	Jonathan Chang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$73.00 ➝ $75.00	Outperform	View details for Leerink Partners rating of Zai Lab (NASDAQ:ZLAB) on 6/30/2025
NUVL Nuvalent	$76.67 -5.3%	6/24/2025	Andrew Berens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$125.00 ➝ $140.00	Outperform	View details for Leerink Partners rating of Nuvalent (NASDAQ:NUVL) on 6/24/2025
ABT Abbott Laboratories	$136.22 +1.2%	6/16/2025		Initiated Coverage	$143.00	Market Perform	View details for Leerink Partners rating of Abbott Laboratories (NYSE:ABT) on 6/16/2025
MDT Medtronic	$94.91 -0.7%	6/16/2025	Mike Kratky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$110.00	Outperform	View details for Leerink Partners rating of Medtronic (NYSE:MDT) on 6/16/2025
BSX Boston Scientific	$97.84 -0.4%	6/16/2025	Mike Kratky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$118.00	Outperform	View details for Leerink Partners rating of Boston Scientific (NYSE:BSX) on 6/16/2025
IDXX IDEXX Laboratories	$656.16 +0.1%	6/11/2025	Daniel Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$515.00 ➝ $580.00	Outperform	View details for Leerink Partners rating of IDEXX Laboratories (NASDAQ:IDXX) on 6/11/2025
SMMT Summit Therapeutics	$18.89 -1.8%	6/11/2025	Daina Graybosch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$12.00	Underperform	View details for Leerink Partners rating of Summit Therapeutics (NASDAQ:SMMT) on 6/11/2025
INSM Insmed	$144.76 -0.8%	6/10/2025	Joseph Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$100.00 ➝ $115.00	Outperform	View details for Leerink Partners rating of Insmed (NASDAQ:INSM) on 6/10/2025
DHR Danaher	$193.31 -1.0%	4/17/2025		Lower Price Target	$260.00 ➝ $225.00	Outperform	View details for Leerink Partners rating of Danaher (NYSE:DHR) on 4/17/2025
DHR Danaher	$193.31 -1.0%	4/23/2025		Boost Price Target	$225.00 ➝ $230.00	Outperform	View details for Leerink Partners rating of Danaher (NYSE:DHR) on 4/23/2025
BNTX BioNTech	$96.22 -0.1%	6/2/2025	Daina Graybosch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$112.00		View details for Leerink Partners rating of BioNTech (NASDAQ:BNTX) on 6/2/2025
ARVN Arvinas	$7.52 -2.6%	6/2/2025	Andrew Berens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00 ➝ $9.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Arvinas (NASDAQ:ARVN) on 6/2/2025
A Agilent Technologies	$126.24 -1.1%	5/30/2025		Boost Price Target	$135.00	Buy	View details for Leerink Partners rating of Agilent Technologies (NYSE:A) on 5/30/2025
RCKT Rocket Pharmaceuticals	$3.07 -3.2%	5/28/2025	Mani Foroohar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$37.00 ➝ $8.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/28/2025
FULC Fulcrum Therapeutics	$7.39 -2.0%	5/23/2025	Joseph Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$4.00 ➝ $12.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Fulcrum Therapeutics (NASDAQ:FULC) on 5/23/2025
ITOS iTeos Therapeutics	$10.15	5/14/2025	Daina Graybosch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$47.00 ➝ $9.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of iTeos Therapeutics (NASDAQ:ITOS) on 5/14/2025
JNJ Johnson & Johnson	$175.97 +1.0%	5/13/2025	David Risinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$169.00 ➝ $153.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Johnson & Johnson (NYSE:JNJ) on 5/13/2025
HALO Halozyme Therapeutics	$77.81 +1.5%	5/13/2025		Downgrade	$47.00	Market Perform ➝ Underperform	View details for Leerink Partners rating of Halozyme Therapeutics (NASDAQ:HALO) on 5/13/2025
AMLX Amylyx Pharmaceuticals	$13.31 +0.5%	5/7/2025	Marc Goodman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$4.00 ➝ $10.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 5/7/2025
VRTX Vertex Pharmaceuticals	$383.12 -1.0%	5/6/2025	David Risinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$550.00 ➝ $503.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/6/2025
QTRX Quanterix	$5.43 -2.7%	4/30/2025	Puneet Souda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$12.00 ➝ $8.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Quanterix (NASDAQ:QTRX) on 4/30/2025
NEO NeoGenomics	$8.52 -1.2%	4/30/2025	Puneet Souda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$25.00 ➝ $9.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of NeoGenomics (NASDAQ:NEO) on 4/30/2025
AKBA Akebia Therapeutics	$2.82 -4.7%	4/28/2025	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$7.00	Outperform	View details for Leerink Partners rating of Akebia Therapeutics (NASDAQ:AKBA) on 4/28/2025
IRWD Ironwood Pharmaceuticals	$1.41 -3.4%	4/14/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$3.00 ➝ $1.00	Market Perform	View details for Leerink Partners rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 4/14/2025
SYRE Spyre Therapeutics	$14.88 -2.9%	4/8/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$45.00	Outperform	View details for Leerink Partners rating of Spyre Therapeutics (NASDAQ:SYRE) on 4/8/2025
CMPX Compass Therapeutics	$3.39 -7.9%	4/2/2025	Andrew Berens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$4.00 ➝ $6.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Compass Therapeutics (NASDAQ:CMPX) on 4/2/2025
AIRS AirSculpt Technologies	$6.55 +6.5%	3/31/2025	Whit Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$6.50 ➝ $2.50	Market Perform	View details for Leerink Partners rating of AirSculpt Technologies (NASDAQ:AIRS) on 3/31/2025
EQ Equillium	$1.46 -2.7%	3/28/2025	Thomas Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$3.00 ➝ $1.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Equillium (NASDAQ:EQ) on 3/28/2025
RGNX REGENXBIO	$8.89 -5.0%	3/18/2025		Set Price Target	$24.00		View details for Leerink Partners rating of REGENXBIO (NASDAQ:RGNX) on 3/18/2025
OPT Opthea	$3.41	3/25/2025	Marc Goodman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$12.00 ➝ $1.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Opthea (NASDAQ:OPT) on 3/25/2025
LXEO Lexeo Therapeutics	$5.15 -5.7%	3/24/2025	Mani Foroohar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$19.00 ➝ $18.00	Outperform	View details for Leerink Partners rating of Lexeo Therapeutics (NASDAQ:LXEO) on 3/24/2025
MEDP Medpace	$498.60 -0.7%	3/24/2025	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$330.00	Market Perform	View details for Leerink Partners rating of Medpace (NASDAQ:MEDP) on 3/24/2025
STTK Shattuck Labs	$2.28 +2.2%	3/17/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$4.00	Outperform	View details for Leerink Partners rating of Shattuck Labs (NASDAQ:STTK) on 3/17/2025
NRIX Nurix Therapeutics	$8.44 -5.9%	3/17/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$16.00	Market Perform	View details for Leerink Partners rating of Nurix Therapeutics (NASDAQ:NRIX) on 3/17/2025
TENX Tenax Therapeutics	$6.41	3/10/2025		Set Price Target	$20.00		View details for Leerink Partners rating of Tenax Therapeutics (NASDAQ:TENX) on 3/10/2025
XERS Xeris Biopharma	$7.72 -7.0%	3/7/2025	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$5.00 ➝ $6.00	Outperform	View details for Leerink Partners rating of Xeris Biopharma (NASDAQ:XERS) on 3/7/2025
CRMD CorMedix	$11.20 -4.2%	3/7/2025	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$18.00	Outperform	View details for Leerink Partners rating of CorMedix (NASDAQ:CRMD) on 3/7/2025
LXRX Lexicon Pharmaceuticals	$1.19 -2.5%	3/4/2025	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$2.00 ➝ $1.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 3/4/2025
PLRX Pliant Therapeutics	$1.43 -4.0%	3/3/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$33.00 ➝ $2.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Pliant Therapeutics (NASDAQ:PLRX) on 3/3/2025
RXRX Recursion Pharmaceuticals	$4.91 -0.4%	2/28/2025	Mani Foroohar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$7.00 ➝ $6.00	Market Perform	View details for Leerink Partners rating of Recursion Pharmaceuticals (NASDAQ:RXRX) on 2/28/2025
HIMS Hims & Hers Health	$57.74 +2.7%	2/25/2025	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$24.00 ➝ $40.00	Market Perform	View details for Leerink Partners rating of Hims & Hers Health (NYSE:HIMS) on 2/25/2025
MAZE Maze Therapeutics	$22.94 -2.3%	2/25/2025	Joseph Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$28.00	Outperform	View details for Leerink Partners rating of Maze Therapeutics (NASDAQ:MAZE) on 2/25/2025
BBNX Beta Bionics	$22.46 -2.6%	2/24/2025	Mike Kratky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$28.00	Outperform	View details for Leerink Partners rating of Beta Bionics (NASDAQ:BBNX) on 2/24/2025
MGM MGM Resorts International	$35.83 -0.3%	2/13/2025		Downgrade		Market Perform	View details for Leerink Partners rating of MGM Resorts International (NYSE:MGM) on 2/13/2025
LLY Eli Lilly and Company	$753.52 -1.2%	1/17/2025	Andrew Berens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$950.00		View details for Leerink Partners rating of Eli Lilly and Company (NYSE:LLY) on 1/17/2025
ATYR aTyr Pharma	$0.99 -5.5%	2/18/2025	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$16.00	Outperform	View details for Leerink Partners rating of aTyr Pharma (NASDAQ:ATYR) on 2/18/2025
TXG 10x Genomics	$13.04 -1.7%	2/13/2025	Mike Kratky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$25.00 ➝ $12.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of 10x Genomics (NASDAQ:TXG) on 2/13/2025
GMAB Genmab A/S	$28.28 +0.9%	2/13/2025	Jonathan Chang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$27.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Genmab A/S (NASDAQ:GMAB) on 2/13/2025
CVS CVS Health	$74.95 +0.7%	2/13/2025	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$55.00 ➝ $75.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of CVS Health (NYSE:CVS) on 2/13/2025
CVS CVS Health	$74.95 +0.7%	2/11/2025		Boost Price Target	$51.00 ➝ $55.00	Market Perform	View details for Leerink Partners rating of CVS Health (NYSE:CVS) on 2/11/2025

AXSM Axsome Therapeutics	$115.95 -2.3%	2/10/2025	Marc Goodman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$110.00 ➝ $150.00	Outperform	View details for Leerink Partners rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/10/2025
DOCS Doximity	$72.89 -1.0%	2/7/2025	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$60.00 ➝ $90.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Doximity (NASDAQ:DOCS) on 2/7/2025
HOLX Hologic	$66.33 -2.8%	2/6/2025	Puneet Souda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$80.00 ➝ $75.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Hologic (NASDAQ:HOLX) on 2/6/2025
REGN Regeneron Pharmaceuticals	$591.99 -1.1%	2/5/2025	David Risinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$762.00 ➝ $834.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/5/2025
REGN Regeneron Pharmaceuticals	$591.99 -1.1%	2/4/2025		Lower Price Target	$980.00 ➝ $862.00	Market Perform	View details for Leerink Partners rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/4/2025
ISRG Intuitive Surgical	$438.72 +0.7%	1/27/2025		Boost Price Target	$490.00 ➝ $548.00		View details for Leerink Partners rating of Intuitive Surgical (NASDAQ:ISRG) on 1/27/2025
JNJ Johnson & Johnson	$175.97 +1.0%	1/23/2025	David Risinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$182.00 ➝ $169.00	Outperform	View details for Leerink Partners rating of Johnson & Johnson (NYSE:JNJ) on 1/23/2025
MRNA Moderna	$25.24 -0.8%	1/16/2025		Lower Price Target	$31.00 ➝ $27.00	Underweight	View details for Leerink Partners rating of Moderna (NASDAQ:MRNA) on 1/16/2025
FDMT 4D Molecular Therapeutics	$6.60 -7.0%	1/13/2025	Mani Foroohar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$31.00 ➝ $27.00	Outperform	View details for Leerink Partners rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 1/13/2025
SPRY ARS Pharmaceuticals	$9.79 -1.4%	1/13/2025	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$26.00 ➝ $27.00	Outperform	View details for Leerink Partners rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 1/13/2025
VIR Vir Biotechnology	$5.18	1/13/2025	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$18.00 ➝ $20.00	Outperform	View details for Leerink Partners rating of Vir Biotechnology (NASDAQ:VIR) on 1/13/2025
MRK Merck & Co., Inc.	$81.41 -0.1%	1/13/2025	Daina Graybosch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$136.00 ➝ $119.00	Outperform	View details for Leerink Partners rating of Merck & Co., Inc. (NYSE:MRK) on 1/13/2025
DGX Quest Diagnostics	$183.69 +0.2%	1/6/2025		Upgrade	$169.00 ➝ $174.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Quest Diagnostics (NYSE:DGX) on 1/6/2025
ALGN Align Technology	$131.39 -0.9%	1/6/2025		Upgrade	$235.00 ➝ $280.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Align Technology (NASDAQ:ALGN) on 1/6/2025
KYMR Kymera Therapeutics	$49.13 -4.0%	12/27/2024		Reiterated Rating	$60.00 ➝ $60.00	Outperform	View details for Leerink Partners rating of Kymera Therapeutics (NASDAQ:KYMR) on 12/27/2024
LVTX LAVA Therapeutics	$1.49 +1.0%	12/12/2024		Reiterated Rating	$11.00 ➝ $2.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of LAVA Therapeutics (NASDAQ:LVTX) on 12/12/2024
QURE uniQure	$13.87 -5.9%	12/11/2024		Boost Price Target	$26.00 ➝ $44.00	Outperform	View details for Leerink Partners rating of uniQure (NASDAQ:QURE) on 12/11/2024
QTTB Q32 Bio	$1.85 +6.3%	12/11/2024		Reiterated Rating	$68.00 ➝ $9.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Q32 Bio (NASDAQ:QTTB) on 12/11/2024
ANIP ANI Pharmaceuticals	$96.79 -0.7%	12/11/2024		Initiated Coverage	$80.00	Outperform	View details for Leerink Partners rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 12/11/2024
MYGN Myriad Genetics	$7.77 +1.2%	12/9/2024		Downgrade	$30.00 ➝ $21.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Myriad Genetics (NASDAQ:MYGN) on 12/9/2024
OKUR OnKure Therapeutics	$2.57 +3.6%	12/5/2024		Initiated Coverage	$33.00	Outperform	View details for Leerink Partners rating of OnKure Therapeutics (NASDAQ:OKUR) on 12/5/2024
RLMD Relmada Therapeutics	$1.53 -7.3%	12/4/2024		Reiterated Rating	$10.00 ➝ $1.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Relmada Therapeutics (NASDAQ:RLMD) on 12/4/2024
RLAY Relay Therapeutics	$4.66 +2.4%	12/4/2024		Lower Price Target	$19.00 ➝ $18.00	Outperform	View details for Leerink Partners rating of Relay Therapeutics (NASDAQ:RLAY) on 12/4/2024
JANX Janux Therapeutics	$23.45 -3.9%	12/3/2024		Boost Price Target	$79.00 ➝ $91.00	Outperform	View details for Leerink Partners rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024
CLYM Climb Bio	$2.31 +3.1%	12/2/2024		Initiated Coverage	$10.00	Outperform	View details for Leerink Partners rating of Climb Bio (NASDAQ:CLYM) on 12/2/2024
ZTS Zoetis	$145.82 -0.9%	12/2/2024		Initiated Coverage	$215.00	Outperform	View details for Leerink Partners rating of Zoetis (NYSE:ZTS) on 12/2/2024
IDXX IDEXX Laboratories	$656.16 +0.1%	12/2/2024		Initiated Coverage	$500.00	Outperform	View details for Leerink Partners rating of IDEXX Laboratories (NASDAQ:IDXX) on 12/2/2024
ELAN Elanco Animal Health	$19.18 +0.4%	12/2/2024		Initiated Coverage	$14.00	Market Perform	View details for Leerink Partners rating of Elanco Animal Health (NYSE:ELAN) on 12/2/2024
AMGN Amgen	$285.41 +3.5%	11/27/2024		Lower Price Target	$349.00 ➝ $302.00		View details for Leerink Partners rating of Amgen (NASDAQ:AMGN) on 11/27/2024
JANX Janux Therapeutics	$23.45 -3.9%	11/22/2024		Initiated Coverage	$79.00	Outperform	View details for Leerink Partners rating of Janux Therapeutics (NASDAQ:JANX) on 11/22/2024
ABBV AbbVie	$222.29 +0.1%	11/22/2024		Upgrade	$206.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of AbbVie (NYSE:ABBV) on 11/22/2024
IQV IQVIA	$187.29 -1.5%	11/19/2024		Reiterated Rating	$260.00 ➝ $248.00	Outperform	View details for Leerink Partners rating of IQVIA (NYSE:IQV) on 11/19/2024
RCKT Rocket Pharmaceuticals	$3.07 -3.2%	11/19/2024		Lower Price Target	$46.00 ➝ $44.00	Outperform	View details for Leerink Partners rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/19/2024
EHAB Enhabit	$8.19 +1.6%	11/19/2024		Reiterated Rating	$8.50 ➝ $8.00	Market Perform	View details for Leerink Partners rating of Enhabit (NYSE:EHAB) on 11/19/2024
ICLR Icon	$174.00 -3.0%	11/19/2024		Reiterated Rating	$270.00 ➝ $255.00	Outperform	View details for Leerink Partners rating of Icon (NASDAQ:ICLR) on 11/19/2024
ACRS Aclaris Therapeutics	$1.91 -2.1%	11/19/2024		Upgrade	$2.00 ➝ $7.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/19/2024
CMPX Compass Therapeutics	$3.39 -7.9%	11/15/2024		Downgrade	$5.00 ➝ $4.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Compass Therapeutics (NASDAQ:CMPX) on 11/15/2024
LXEO Lexeo Therapeutics	$5.15 -5.7%	11/13/2024		Lower Price Target	$20.00 ➝ $19.00	Outperform	View details for Leerink Partners rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/13/2024
MASS 908 Devices	$7.30 +7.0%	11/13/2024		Reiterated Rating	$12.00 ➝ $4.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of 908 Devices (NASDAQ:MASS) on 11/13/2024
ARDT Ardent Health	$12.82 -3.7%	11/12/2024		Boost Price Target	$23.00 ➝ $25.00	Outperform	View details for Leerink Partners rating of Ardent Health (NYSE:ARDT) on 11/12/2024
NGNE Neurogene	$17.20 -7.9%	11/12/2024		Boost Price Target	$45.00 ➝ $72.00	Outperform	View details for Leerink Partners rating of Neurogene (NASDAQ:NGNE) on 11/12/2024
BMY Bristol Myers Squibb	$45.05 -1.2%	11/12/2024		Upgrade	$55.00 ➝ $73.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Bristol Myers Squibb (NYSE:BMY) on 11/12/2024
TECX Tectonic Therapeutic	$14.98 -4.2%	11/11/2024		Boost Price Target	$49.00 ➝ $69.00	Outperform	View details for Leerink Partners rating of Tectonic Therapeutic (NASDAQ:TECX) on 11/11/2024
XRAY DENTSPLY SIRONA	$13.16 -1.9%	11/7/2024		Downgrade		Outperform ➝ Market Perform	View details for Leerink Partners rating of DENTSPLY SIRONA (NASDAQ:XRAY) on 11/7/2024
ZYME Zymeworks	$16.25 -1.5%	11/7/2024		Upgrade	$10.00 ➝ $25.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Zymeworks (NYSE:ZYME) on 11/7/2024
BEAM Beam Therapeutics	$24.32 -3.1%	11/6/2024		Upgrade	$27.00 ➝ $39.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Beam Therapeutics (NASDAQ:BEAM) on 11/6/2024
IDYA IDEAYA Biosciences	$25.74 -1.8%	11/5/2024		Downgrade	$41.00 ➝ $27.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/5/2024
ZURA Zura Bio	$1.99 -2.9%	11/4/2024		Initiated Coverage	$15.00	Outperform	View details for Leerink Partners rating of Zura Bio (NASDAQ:ZURA) on 11/4/2024
NVST Envista	$20.91 -0.6%	10/31/2024		Upgrade	$16.00 ➝ $23.00	Underperform ➝ Market Perform	View details for Leerink Partners rating of Envista (NYSE:NVST) on 10/31/2024
AQST Aquestive Therapeutics	$5.67 +14.8%	10/25/2024		Boost Price Target	$12.00 ➝ $13.00	Outperform	View details for Leerink Partners rating of Aquestive Therapeutics (NASDAQ:AQST) on 10/25/2024

DXCM DexCom	$67.45 -11.0%	10/25/2024		Lower Price Target	$90.00 ➝ $87.00	Outperform	View details for Leerink Partners rating of DexCom (NASDAQ:DXCM) on 10/25/2024
ICLR Icon	$174.00 -3.0%	10/25/2024		Lower Price Target	$376.00 ➝ $270.00	Outperform	View details for Leerink Partners rating of Icon (NASDAQ:ICLR) on 10/25/2024
TENX Tenax Therapeutics	$6.41	10/24/2024		Initiated Coverage	$16.00	Outperform	View details for Leerink Partners rating of Tenax Therapeutics (NASDAQ:TENX) on 10/24/2024
GILD Gilead Sciences	$114.09 +0.4%	10/21/2024		Upgrade	$74.00 ➝ $96.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Gilead Sciences (NASDAQ:GILD) on 10/21/2024
TNYA Tenaya Therapeutics	$1.41 +6.8%	10/18/2024		Reiterated Rating		Outperform	View details for Leerink Partners rating of Tenaya Therapeutics (NASDAQ:TNYA) on 10/18/2024
AMLX Amylyx Pharmaceuticals	$13.31 +0.5%	10/18/2024	Marc Goodman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$4.00	Market Perform	View details for Leerink Partners rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 10/18/2024
LXRX Lexicon Pharmaceuticals	$1.19 -2.5%	10/18/2024	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$6.00	Outperform	View details for Leerink Partners rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 10/18/2024
ISRG Intuitive Surgical	$438.72 +0.7%	10/17/2024		Boost Price Target	$489.00 ➝ $502.00		View details for Leerink Partners rating of Intuitive Surgical (NASDAQ:ISRG) on 10/17/2024
BBIO BridgeBio Pharma	$52.37 -1.8%	10/17/2024		Lower Price Target	$47.00 ➝ $46.00	Outperform	View details for Leerink Partners rating of BridgeBio Pharma (NASDAQ:BBIO) on 10/17/2024
MIRM Mirum Pharmaceuticals	$74.38 -1.2%	10/17/2024		Boost Price Target	$47.00 ➝ $49.00	Outperform	View details for Leerink Partners rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 10/17/2024
ILMN Illumina	$102.75 -0.3%	10/17/2024		Boost Price Target	$160.00 ➝ $200.00	Outperform	View details for Leerink Partners rating of Illumina (NASDAQ:ILMN) on 10/17/2024
MASS 908 Devices	$7.30 +7.0%	10/17/2024		Lower Price Target	$15.00 ➝ $12.00	Outperform	View details for Leerink Partners rating of 908 Devices (NASDAQ:MASS) on 10/17/2024
NTRA Natera	$181.11 +0.7%	10/17/2024		Boost Price Target	$140.00 ➝ $150.00	Outperform	View details for Leerink Partners rating of Natera (NASDAQ:NTRA) on 10/17/2024
RVTY Revvity	$86.68 -1.2%	10/17/2024		Boost Price Target	$130.00 ➝ $135.00	Outperform	View details for Leerink Partners rating of Revvity (NYSE:RVTY) on 10/17/2024
TWST Twist Bioscience	$27.89 -0.2%	10/17/2024		Boost Price Target	$45.00 ➝ $48.00	Market Perform	View details for Leerink Partners rating of Twist Bioscience (NASDAQ:TWST) on 10/17/2024
VCYT Veracyte	$34.11 +2.6%	10/17/2024		Boost Price Target	$35.00 ➝ $40.00	Outperform	View details for Leerink Partners rating of Veracyte (NASDAQ:VCYT) on 10/17/2024
GH Guardant Health	$59.15 +0.6%	10/17/2024		Lower Price Target	$60.00 ➝ $50.00	Outperform	View details for Leerink Partners rating of Guardant Health (NASDAQ:GH) on 10/17/2024
WVE WAVE Life Sciences	$6.89 -1.0%	10/16/2024		Boost Price Target	$20.00 ➝ $22.00	Outperform	View details for Leerink Partners rating of WAVE Life Sciences (NASDAQ:WVE) on 10/16/2024
VYGR Voyager Therapeutics	$4.27 -4.9%	10/16/2024		Initiated Coverage	$15.00	Outperform	View details for Leerink Partners rating of Voyager Therapeutics (NASDAQ:VYGR) on 10/16/2024
MNMD Mind Medicine (MindMed)	$9.04 -4.6%	10/14/2024		Initiated Coverage	$20.00	Outperform	View details for Leerink Partners rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 10/14/2024
STOK Stoke Therapeutics	$22.90 -2.6%	10/14/2024		Initiated Coverage	$18.00	Outperform	View details for Leerink Partners rating of Stoke Therapeutics (NASDAQ:STOK) on 10/14/2024
HOLX Hologic	$66.33 -2.8%	10/8/2024		Lower Price Target	$95.00 ➝ $90.00	Outperform	View details for Leerink Partners rating of Hologic (NASDAQ:HOLX) on 10/8/2024
TVTX Travere Therapeutics	$24.85 +2.7%	10/8/2024		Reiterated Rating	$20.00 ➝ $20.00	Outperform	View details for Leerink Partners rating of Travere Therapeutics (NASDAQ:TVTX) on 10/8/2024
COR Cencora	$290.32 -0.2%	10/7/2024		Lower Price Target	$277.00 ➝ $275.00	Outperform	View details for Leerink Partners rating of Cencora (NYSE:COR) on 10/7/2024
MCK McKesson	$698.07 +1.2%	10/7/2024		Lower Price Target	$665.00 ➝ $630.00	Outperform	View details for Leerink Partners rating of McKesson (NYSE:MCK) on 10/7/2024
HUM Humana	$252.39 -4.7%	10/2/2024		Downgrade	$400.00 ➝ $250.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Humana (NYSE:HUM) on 10/2/2024
AQST Aquestive Therapeutics	$5.67 +14.8%	9/30/2024		Reiterated Rating	$10.00 ➝ $12.00	Outperform	View details for Leerink Partners rating of Aquestive Therapeutics (NASDAQ:AQST) on 9/30/2024
AGIO Agios Pharmaceuticals	$37.70 -0.7%	9/27/2024		Downgrade	$60.00 ➝ $56.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 9/27/2024
REGN Regeneron Pharmaceuticals	$591.99 -1.1%	9/24/2024		Reiterated Rating	$1,175.00 ➝ $1,077.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 9/24/2024
BHVN Biohaven	$14.34 -7.6%	9/23/2024		Boost Price Target	$55.00 ➝ $60.00	Outperform	View details for Leerink Partners rating of Biohaven (NYSE:BHVN) on 9/23/2024
SPRY ARS Pharmaceuticals	$9.79 -1.4%	9/20/2024		Boost Price Target	$21.00 ➝ $25.00	Outperform	View details for Leerink Partners rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 9/20/2024
APLT Applied Therapeutics	$0.43 -2.4%	9/19/2024		Boost Price Target	$11.00 ➝ $14.00	Outperform	View details for Leerink Partners rating of Applied Therapeutics (NASDAQ:APLT) on 9/19/2024
FDMT 4D Molecular Therapeutics	$6.60 -7.0%	9/19/2024		Reiterated Rating	$40.00 ➝ $36.00	Outperform	View details for Leerink Partners rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 9/19/2024
PGNY Progyny	$21.62 -4.0%	9/19/2024		Lower Price Target	$25.00 ➝ $21.00	Market Perform	View details for Leerink Partners rating of Progyny (NASDAQ:PGNY) on 9/19/2024
ICLR Icon	$174.00 -3.0%	9/18/2024		Initiated Coverage	$379.00	Outperform	View details for Leerink Partners rating of Icon (NASDAQ:ICLR) on 9/18/2024
MRNA Moderna	$25.24 -0.8%	9/17/2024		Lower Price Target	$60.00 ➝ $48.00	Underperform	View details for Leerink Partners rating of Moderna (NASDAQ:MRNA) on 9/17/2024
ORKA Oruka Therapeutics	$15.55 -6.2%	9/17/2024		Initiated Coverage	$44.00	Outperform	View details for Leerink Partners rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/17/2024
FULC Fulcrum Therapeutics	$7.39 -2.0%	9/12/2024		Reiterated Rating	$4.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Fulcrum Therapeutics (NASDAQ:FULC) on 9/12/2024
INSP Inspire Medical Systems	$79.86 -4.2%	9/10/2024		Boost Price Target	$167.00 ➝ $197.00	Market Perform	View details for Leerink Partners rating of Inspire Medical Systems (NYSE:INSP) on 9/10/2024
MNKD MannKind	$5.43 -3.2%	9/9/2024		Initiated Coverage	$7.00 ➝ $8.00	Outperform	View details for Leerink Partners rating of MannKind (NASDAQ:MNKD) on 9/9/2024
PLRX Pliant Therapeutics	$1.43 -4.0%	9/9/2024		Initiated Coverage	$46.00 ➝ $33.00	Outperform	View details for Leerink Partners rating of Pliant Therapeutics (NASDAQ:PLRX) on 9/9/2024
PRTC PureTech Health	$16.93 +15.1%	9/9/2024		Initiated Coverage	$58.00 ➝ $45.00	Outperform	View details for Leerink Partners rating of PureTech Health (NASDAQ:PRTC) on 9/9/2024
TRVI Trevi Therapeutics	$8.15 -4.6%	9/9/2024		Initiated Coverage	$6.00 ➝ $7.00	Outperform	View details for Leerink Partners rating of Trevi Therapeutics (NASDAQ:TRVI) on 9/9/2024
IMUX Immunic	$0.85 +0.6%	9/9/2024		Reiterated Rating	$5.00	Outperform	View details for Leerink Partners rating of Immunic (NASDAQ:IMUX) on 9/9/2024
KYMR Kymera Therapeutics	$49.13 -4.0%	9/9/2024		Reiterated Rating	$60.00	Outperform	View details for Leerink Partners rating of Kymera Therapeutics (NASDAQ:KYMR) on 9/9/2024
IRWD Ironwood Pharmaceuticals	$1.41 -3.4%	9/9/2024		Initiated Coverage	$5.00	Market Perform	View details for Leerink Partners rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 9/9/2024
GERN Geron	$1.32	9/9/2024		Initiated Coverage	$7.00	Outperform	View details for Leerink Partners rating of Geron (NASDAQ:GERN) on 9/9/2024
MCK McKesson	$698.07 +1.2%	9/5/2024		Lower Price Target	$670.00 ➝ $665.00	Outperform	View details for Leerink Partners rating of McKesson (NYSE:MCK) on 9/5/2024
PCVX Vaxcyte	$31.75 -2.6%	9/3/2024		Boost Price Target	$106.00 ➝ $153.00	Outperform	View details for Leerink Partners rating of Vaxcyte (NASDAQ:PCVX) on 9/3/2024
RXRX Recursion Pharmaceuticals	$4.91 -0.4%	9/3/2024		Lower Price Target	$9.00 ➝ $8.00	Market Perform	View details for Leerink Partners rating of Recursion Pharmaceuticals (NASDAQ:RXRX) on 9/3/2024

PEN Penumbra	$255.90 -0.7%	9/3/2024		Initiated Coverage	$263.00	Outperform	View details for Leerink Partners rating of Penumbra (NYSE:PEN) on 9/3/2024
TXG 10x Genomics	$13.04 -1.7%	9/3/2024		Initiated Coverage	$35.00	Outperform	View details for Leerink Partners rating of 10x Genomics (NASDAQ:TXG) on 9/3/2024
SPRY ARS Pharmaceuticals	$9.79 -1.4%	8/12/2024		Boost Price Target	$19.00 ➝ $20.00	Outperform	View details for Leerink Partners rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 8/12/2024
ARDT Ardent Health	$12.82 -3.7%	8/12/2024		Initiated Coverage	$23.00	Outperform	View details for Leerink Partners rating of Ardent Health (NYSE:ARDT) on 8/12/2024
ARCT Arcturus Therapeutics	$20.46 +4.3%	8/12/2024		Initiated Coverage	$70.00	Outperform	View details for Leerink Partners rating of Arcturus Therapeutics (NASDAQ:ARCT) on 8/12/2024
PGNY Progyny	$21.62 -4.0%	8/7/2024		Downgrade	$31.00 ➝ $25.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Progyny (NASDAQ:PGNY) on 8/7/2024
TBPH Theravance Biopharma	$13.88 -4.1%	8/6/2024		Downgrade	$15.00 ➝ $10.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Theravance Biopharma (NASDAQ:TBPH) on 8/6/2024
WAT Waters	$301.43 -1.6%	8/1/2024		Upgrade	$325.00 ➝ $375.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Waters (NYSE:WAT) on 8/1/2024
TECX Tectonic Therapeutic	$14.98 -4.2%	7/24/2024		Initiated Coverage	$49.00	Outperform	View details for Leerink Partners rating of Tectonic Therapeutic (NASDAQ:TECX) on 7/24/2024
DHR Danaher	$193.31 -1.0%	7/24/2024		Boost Price Target	$275.00 ➝ $280.00	Outperform	View details for Leerink Partners rating of Danaher (NYSE:DHR) on 7/24/2024
HCA HCA Healthcare	$402.06 +0.2%	7/24/2024		Boost Price Target	$367.00 ➝ $396.00	Outperform	View details for Leerink Partners rating of HCA Healthcare (NYSE:HCA) on 7/24/2024
IONS Ionis Pharmaceuticals	$61.01 -1.2%	7/24/2024		Upgrade	$53.00 ➝ $62.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 7/24/2024
ALMS Alumis	$4.17 -2.8%	7/23/2024		Initiated Coverage	$29.00	Outperform	View details for Leerink Partners rating of Alumis (NASDAQ:ALMS) on 7/23/2024
CELC Celcuity	$51.88 -5.7%	7/22/2024		Initiated Coverage	$29.00	Outperform	View details for Leerink Partners rating of Celcuity (NASDAQ:CELC) on 7/22/2024
BNTC Benitec Biopharma	$13.45 -3.9%	7/22/2024		Initiated Coverage	$13.00	Outperform	View details for Leerink Partners rating of Benitec Biopharma (NASDAQ:BNTC) on 7/22/2024
LNTH Lantheus	$50.41 -2.2%	7/11/2024		Boost Price Target	$106.00 ➝ $127.00	Outperform	View details for Leerink Partners rating of Lantheus (NASDAQ:LNTH) on 7/11/2024
EHC Encompass Health	$123.94 -1.1%	7/10/2024		Initiated Coverage	$100.00	Outperform	View details for Leerink Partners rating of Encompass Health (NYSE:EHC) on 7/10/2024
HLVX HilleVax	$2.09	7/9/2024		Downgrade	$28.00 ➝ $2.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of HilleVax (NASDAQ:HLVX) on 7/9/2024
RVTY Revvity	$86.68 -1.2%	7/8/2024		Initiated Coverage	$125.00	Outperform	View details for Leerink Partners rating of Revvity (NYSE:RVTY) on 7/8/2024
SDGR Schrodinger	$19.45 -1.0%	7/2/2024		Initiated Coverage	$29.00	Outperform	View details for Leerink Partners rating of Schrodinger (NASDAQ:SDGR) on 7/2/2024
COR Cencora	$290.32 -0.2%	6/27/2024		Reiterated Rating	$275.00 ➝ $275.00	Outperform	View details for Leerink Partners rating of Cencora (NYSE:COR) on 6/27/2024
ALNY Alnylam Pharmaceuticals	$453.56 +0.3%	6/25/2024		Boost Price Target	$138.00 ➝ $159.00	Market Perform	View details for Leerink Partners rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 6/25/2024
SLDB Solid Biosciences	$5.12 -5.9%	6/24/2024		Upgrade	$12.00 ➝ $12.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Solid Biosciences (NASDAQ:SLDB) on 6/24/2024
SRPT Sarepta Therapeutics	$17.43 -5.9%	6/24/2024		Boost Price Target	$165.00 ➝ $230.00	Outperform	View details for Leerink Partners rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/24/2024
MREO Mereo BioPharma Group	$1.74 -1.7%	6/20/2024		Boost Price Target	$6.00 ➝ $8.00	Outperform	View details for Leerink Partners rating of Mereo BioPharma Group (NASDAQ:MREO) on 6/20/2024
QTTB Q32 Bio	$1.85 +6.3%	5/21/2024		Initiated Coverage	$54.00	Outperform	View details for Leerink Partners rating of Q32 Bio (NASDAQ:QTTB) on 5/21/2024
BOLT Bolt Biotherapeutics	$5.23 -1.1%	5/15/2024		Reiterated Rating	$60.00 ➝ $20.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 5/15/2024
AIRS AirSculpt Technologies	$6.55 +6.5%	5/14/2024		Downgrade	$8.25 ➝ $5.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of AirSculpt Technologies (NASDAQ:AIRS) on 5/14/2024
EHAB Enhabit	$8.19 +1.6%	5/14/2024		Upgrade	$8.50	Underperform ➝ Market Perform	View details for Leerink Partners rating of Enhabit (NYSE:EHAB) on 5/14/2024
AQST Aquestive Therapeutics	$5.67 +14.8%	5/10/2024		Initiated Coverage	$8.00	Outperform	View details for Leerink Partners rating of Aquestive Therapeutics (NASDAQ:AQST) on 5/10/2024
MYGN Myriad Genetics	$7.77 +1.2%	5/8/2024		Upgrade	$25.00 ➝ $35.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Myriad Genetics (NASDAQ:MYGN) on 5/8/2024
CVS CVS Health	$74.95 +0.7%	5/1/2024		Reiterated Rating	$87.00 ➝ $60.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of CVS Health (NYSE:CVS) on 5/1/2024
LXRX Lexicon Pharmaceuticals	$1.19 -2.5%	4/30/2024		Initiated Coverage	$5.00	Outperform	View details for Leerink Partners rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 4/30/2024
XOMA XOMA Royalty	$36.70 -2.4%	4/29/2024		Initiated Coverage	$40.00	Outperform	View details for Leerink Partners rating of XOMA Royalty (NASDAQ:XOMA) on 4/29/2024
NGNE Neurogene	$17.20 -7.9%	4/29/2024		Initiated Coverage	$46.00	Outperform	View details for Leerink Partners rating of Neurogene (NASDAQ:NGNE) on 4/29/2024
IMCR Immunocore	$32.60 -2.5%	4/29/2024		Initiated Coverage	$74.00	Outperform	View details for Leerink Partners rating of Immunocore (NASDAQ:IMCR) on 4/29/2024
CVAC CureVac	$5.35	4/25/2024		Downgrade	$12.00 ➝ $4.00	Outperform ➝ Market Perform	View details for Leerink Partners rating of CureVac (NASDAQ:CVAC) on 4/25/2024
TNDM Tandem Diabetes Care	$12.57 -5.1%	4/25/2024		Upgrade	$34.00 ➝ $45.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Tandem Diabetes Care (NASDAQ:TNDM) on 4/25/2024
RNAC Cartesian Therapeutics	$9.44 -8.4%	4/23/2024		Initiated Coverage	$39.00	Outperform	View details for Leerink Partners rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/23/2024
ANAB AnaptysBio	$20.84 -1.1%	4/16/2024		Initiated Coverage	$47.00	Outperform	View details for Leerink Partners rating of AnaptysBio (NASDAQ:ANAB) on 4/16/2024
MNMD Mind Medicine (MindMed)	$9.04 -4.6%	4/15/2024		Initiated Coverage	$20.00	Outperform	View details for Leerink Partners rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 4/15/2024
LENZ LENZ Therapeutics	$42.27 +1.4%	4/15/2024		Initiated Coverage	$32.00	Outperform	View details for Leerink Partners rating of LENZ Therapeutics (NASDAQ:LENZ) on 4/15/2024
ARDX Ardelyx	$6.21 -3.3%	4/5/2024		Initiated Coverage	$14.00	Outperform	View details for Leerink Partners rating of Ardelyx (NASDAQ:ARDX) on 4/5/2024
LRMR Larimar Therapeutics	$4.20 -1.9%	4/3/2024		Initiated Coverage	$25.00	Outperform	View details for Leerink Partners rating of Larimar Therapeutics (NASDAQ:LRMR) on 4/3/2024
NUVL Nuvalent	$76.67 -5.3%	4/1/2024		Upgrade	$69.00 ➝ $110.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of Nuvalent (NASDAQ:NUVL) on 4/1/2024
SGMT Sagimet Biosciences	$6.52 -3.4%	3/25/2024		Initiated Coverage	$26.00	Outperform	View details for Leerink Partners rating of Sagimet Biosciences (NASDAQ:SGMT) on 3/25/2024
WBA Walgreens Boots Alliance	$11.98	3/18/2024		Lower Price Target	$23.00 ➝ $22.00	Market Perform	View details for Leerink Partners rating of Walgreens Boots Alliance (NASDAQ:WBA) on 3/18/2024
MIRM Mirum Pharmaceuticals	$74.38 -1.2%	3/18/2024		Lower Price Target	$44.00 ➝ $43.00	Outperform	View details for Leerink Partners rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 3/18/2024
AMLX Amylyx Pharmaceuticals	$13.31 +0.5%	3/11/2024		Downgrade		Outperform ➝ Market Perform	View details for Leerink Partners rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 3/11/2024
RGNX REGENXBIO	$8.89 -5.0%	3/6/2024		Upgrade	$37.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of REGENXBIO (NASDAQ:RGNX) on 3/6/2024
SPRY ARS Pharmaceuticals	$9.79 -1.4%	3/5/2024		Upgrade	$6.00 ➝ $18.00	Market Perform ➝ Outperform	View details for Leerink Partners rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/5/2024
KYTX Kyverna Therapeutics	$5.80 +15.8%	3/4/2024		Initiated Coverage	$48.00	Outperform	View details for Leerink Partners rating of Kyverna Therapeutics (NASDAQ:KYTX) on 3/4/2024
WBA Walgreens Boots Alliance	$11.98	2/26/2024		Initiated Coverage	$23.00	Market Perform	View details for Leerink Partners rating of Walgreens Boots Alliance (NASDAQ:WBA) on 2/26/2024
XRAY DENTSPLY SIRONA	$13.16 -1.9%	2/26/2024		Initiated Coverage	$42.00	Outperform	View details for Leerink Partners rating of DENTSPLY SIRONA (NASDAQ:XRAY) on 2/26/2024
PGNY Progyny	$21.62 -4.0%	2/26/2024		Initiated Coverage	$49.00	Outperform	View details for Leerink Partners rating of Progyny (NASDAQ:PGNY) on 2/26/2024
PINC Premier	$25.75 -2.5%	2/26/2024		Initiated Coverage	$22.50	Market Perform	View details for Leerink Partners rating of Premier (NASDAQ:PINC) on 2/26/2024
OMI Owens & Minor	$5.24 -5.7%	2/26/2024		Initiated Coverage	$24.00	Market Perform	View details for Leerink Partners rating of Owens & Minor (NYSE:OMI) on 2/26/2024
MCK McKesson	$698.07 +1.2%	2/26/2024		Initiated Coverage	$600.00	Outperform	View details for Leerink Partners rating of McKesson (NYSE:MCK) on 2/26/2024
LH Labcorp	$277.07 0.0%	2/26/2024		Initiated Coverage	$260.00	Outperform	View details for Leerink Partners rating of Labcorp (NYSE:LH) on 2/26/2024
IQV IQVIA	$187.29 -1.5%	2/26/2024		Initiated Coverage	$290.00	Outperform	View details for Leerink Partners rating of IQVIA (NYSE:IQV) on 2/26/2024

MarketBeat Community Rating for Leerink Partners

Community Ranking:		2.6 out of 5 ( 2.6 of 5 stars)
Outperform Votes:		53,904 (Thanks for Voting!)
Underperform Votes:		51,465 (Thanks for Voting!)
Total Votes:		105,369

MarketBeat's community ratings are surveys of what our community members think about Leerink Partners and other research firms. Vote "Outperform" if you believe Leerink Partners's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Leerink Partners's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Leerink Partners Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Leerink Partners

Stock Forecasts and Research Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Leerink Partners Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Leerink Partners

Stock Forecasts and Research Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools